Healthcare Publications Radiotherapy Market Dec 2018

Market Research Future has recently share information about global Radiotherapy Market
And about the predictions and related market Conditions with the opinion to make better
decision for market key players with the SWOT Analysis and path of revenue sources
Global Radiotherapy Market - Overview
Radiotherapy is used for the treatment of various types of cancer. The therapy uses high
power X-rays to destroy cancerous cells. According to the National Cancer Institute, about
50% of cancer patients receive some type of radiation therapy during their treatment. The
radiotherapy treatment are less painful than the chemotherapy and surgeries. The damaged
cells are broken down by the natural process of body.
The cancerous cells get destroyed totally and does not show its presence in future. The time
required is much less in contrast to the chemotherapy. The side effects of the radiotherapy
is also nominal as compared to the chemotherapy. Around 4 out of every 10 people are
treated for cancer undergo radiotherapy. Normally together with other types of treatment
including chemotherapy and surgery. The market for the radiotherapy is increasing as the
treatment is quick and easy. The treatment is more effective than chemotherapy and
surgery. Though treatment has some side effects but the therapy is widely preferred by
doctors.
The Global Radiotherapy Market will grow very rapidly at a rate of 7% CAGR during the
forecasted period 2017-2023.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1526
GE Healthcare (UK), Siemens (Germany), Cardinal Health (U.S.), Nordion (CA), View ray
(U.S.), Fuji Holdings (Japan), Philips Healthcare (U.S.), Shimadzu Corporation (Japan),
Hologic (U.S.), Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray
Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R.
Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion
Medical Systems, Inc. (U.S.), Mitsubishi Electric Corporation (Japan), CIVCO Medical
Solutions (U.S.), Brainlab AG (Germany), PRECISIS AG (Germany), Technicas Radiofiscas
S.L (Spain), Hitachi Ltd. (Japan), Sumitomo Heavy Industries Ltd. (Japan), ProNova
Solutions LLC (U.S.), ProTom International (U.S.), and others are some of the prominent
players at the forefront of competition in the global radiotherapy market and are profiled in
MRFR Analysis.
Industry Updates
Jan, 2018 Varian Medical Systems signed an agreement to acquire Sirtex Medical Limited.
This acquisition expands Varian's addressable market into interventional oncology to
emerge as a global leader in radio embolization.
October, 2017 Varian has launched its radiotherapy device ProBeam Compact single-room
proton therapy system.
July, 2017 View Ray has recently announced the launch of MRI-guided radiation therapy
solution, MRIdian Linac.
Global Radiotherapy Market – Regional:
Geographically, the regional market is segmented into America, Europe, Asia Pacific, and
the Middle East & Africa.
America holds the larger market in the radiotherapy the market increasing due to the
increasing advancement in the technology. The US is the largest market for the
radiotherapy due to the technological advancement. The adoption of new technology is
more in this region as the research and development is also more and developing day by
day. There are many companies who have already captured the market and developed new
technologies for the imaging. The number of cancer patients are more in this region.
Europe is the second largest market owing to the advanced technologies due to increasing
R&D. The European region is having its own set of regulations for the medical regulations.
The expenditures are also more by the government bodies for the healthcare and adoption
for the new and sophisticated technologies.